NEVRO CORP·4

Mar 24, 5:13 PM ET

MacLeod Roderick H. 4

4 · NEVRO CORP · Filed Mar 24, 2025

Insider Transaction Report

Form 4
Period: 2025-03-20
MacLeod Roderick H.
SVP, Chief Financial Officer
Transactions
  • Tax Payment

    Common Stock

    2025-03-20$5.78/sh611$3,532113,387 total
  • Award

    Common Stock

    2025-03-20+1,136113,998 total
Footnotes (2)
  • [F1]Represents Performance Stock Units ("PSUs") initially granted on March 7, 2023 that were subject to a performance-based vesting condition. The Compensation Committee of the Issuer certified the achievement of the first milestone vesting condition upon which a portion of the PSUs vested.
  • [F2]Includes 69,311 restricted stock units.

Documents

1 file
  • 4
    wk-form4_1742850778.xmlPrimary

    FORM 4